Cubist Pharmaceuticals Inc. (CBST) News Nov 18, 20
Post# of 250602
Posted On: 11/18/2014 9:54:14 PM
Cubist Pharmaceuticals Inc. (CBST) News Nov 18, 2014, 5:23 p.m.
MarketWatch News on CBST
Cubist completes exacta, gets good news from FDA two days in a row 6:22 p.m. June 20, 2014 - Russ Britt
Earnings roundup: Cubist, Merck gain as HCA, Bristol-Myers slide 10:48 a.m. April 29, 2014 - Russ Britt
Three biopharma companies poised for product OKs in 2014: analyst 12:51 p.m. Jan. 6, 2014 - Russ Britt
Cubist, Agenus shares soar after experimental drugs pass muster 1:20 p.m. Dec. 16, 2013 - Russ Britt
Cubist, Trius shares keep rocking, while Optimer and Amgen struggle 12:56 p.m. July 31, 2013 - Russ Britt
Cubist Pharmaceuticals adds fire to merger frenzy with two buyouts 5:00 p.m. July 30, 2013 - Russ Britt
Never mind earnings, it's revenue that drives Cubist shares higher 10:19 a.m. July 19, 2013 - Russ Britt
Cubist Q2 profit down 65% amid higher costs 3:39 p.m. July 18, 2013 - MarketWatch.com
Cubist Pharmaceuticals shares leap late after ruling on patent cases 4:16 p.m. May 20, 2013 - Russ Britt
A few wild stock swings in health earnings 4:34 p.m. Jan. 23, 2013 - Russ Britt
Updates, advisories and surprises 4:01 p.m. Oct. 18, 2012 - MarketWatch
Cubist Pharmaceuticals third-quarter net climbs 3:20 p.m. Oct. 18, 2012 - Russ Britt
FactSet estimate on Cubist is 47 cents 3:12 p.m. Oct. 18, 2012 - Russ Britt
Cubist revenue: $238.1 million vs. $201.7 million 3:07 p.m. Oct. 18, 2012 - Russ Britt
Cubust Pharma net 55 cents vs. 33 cents 3:06 p.m. Oct. 18, 2012 - Russ Britt
Charting a bull/bear stalemate 10:52 a.m. Aug. 23, 2012 - Michael Ashbaugh
Hot stocks to watch 7:59 a.m. July 20, 2012 - MarketWatch.com
Cubist Pharma projects annual sales of $2 bln 12:25 p.m. June 11, 2012 - MarketWatch.com
Cubist Pharma profit jumps 45% on Cubicin boost 4:30 p.m. April 18, 2012 - MarketWatch.com
Bearish bets on four stocks 12:46 p.m. April 9, 2012 - The Trading Deck
Loading more headlines...
Advertisement
Other News on CBST
Making Money With Charles Payne: 11/17/14 6:00 p.m. Nov. 17, 2014 - FOXBusiness
Cubist Pharmaceuticals Inc. (CBST): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Nov. 14, 2014 - Zacks.com
10-Q: CUBIST PHARMACEUTICALS INC 9:04 a.m. Nov. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Cubist Pharmaceuticals (CBST) Upgraded From Hold to Buy 9:14 a.m. Nov. 5, 2014 - TheStreet.com
Wedbush Initiates Coverage On Cubist Pharmaceuticals 10:09 a.m. Nov. 4, 2014 - benzinga.com
Biotech Stock Roundup: Beat & Raise Quarter for Amgen, Celgene, Alexion, Biogen - Analyst Blog 12:28 p.m. Oct. 29, 2014 - Zacks.com
Why We Think Cubist Pharmaceuticals Has Incredible Upside 4:34 a.m. Oct. 29, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – MNKD CBST INCY ISIS 1:15 p.m. Oct. 23, 2014 - InvestorPlace.com
Cubist Pharmaceuticals' Q3 Earnings Beat Expectations - Analyst Blog 10:00 a.m. Oct. 23, 2014 - Zacks.com
Trade-Ideas: Cubist Pharmaceuticals (CBST) Is Today's "Storm The Castle" Stock 2:30 p.m. Oct. 22, 2014 - TheStreet.com
Hottest Healthcare Stocks Now – ACHC BSX CBST GSK 8:15 a.m. Oct. 22, 2014 - InvestorPlace.com
Cubist Pharmaceuticals' (CBST) CEO Mike Bonney on Q3 2014 Results - Earnings Call Transcript 10:30 p.m. Oct. 21, 2014 - Seeking Alpha
Cubist net income up 167% 6:14 p.m. Oct. 21, 2014 - Seeking Alpha
Wall Street Breakfast: IBM To Unload Semiconductor Unit - Report 6:33 a.m. Oct. 20, 2014 - Seeking Alpha
Benzinga's Weekend M&A Chatter 8:58 p.m. Oct. 19, 2014 - benzinga.com
Ironwood Pharma begins linaclotide label expansion trial 9:52 a.m. Oct. 16, 2014 - Seeking Alpha
Actavis Expands Antibiotics Presence With Durata Buy 9:58 a.m. Oct. 6, 2014 - Investors Business Daily
InsiderInsights.com Daily Round Up 10/2/14: FGP, INFI, AGCO, OPK 10:14 a.m. Oct. 3, 2014 - Seeking Alpha
FDA approves Salix/Progenics' Relistor 6:07 p.m. Sept. 29, 2014 - Seeking Alpha
Ad Comm supports approval of Moventig for OIC 8:35 a.m. Sept. 26, 2014 - Seeking Alpha
Loading more headlines...
Press Releases on CBST
European Antibiotic Awareness Day Highlights Need for Urgent Action 1:00 a.m. Nov. 17, 2014 - BusinessWire - BZX
Cubist Names Dr. Patrick Vink Chief Operating Officer 7:32 a.m. Nov. 5, 2014 - BusinessWire - BZX
Cubist to Present at Jefferies 2014 Healthcare Conference 9:01 a.m. Nov. 3, 2014 - BusinessWire - BZX
Technical Data on Biotech Equities - Intrexon, Keryx Biopharma, Spectrum Pharma, Sangamo BioSciences, and Cubist Pharma 8:15 a.m. Oct. 21, 2014 - PR Newswire - PRF
Cubist Pharmaceuticals Names Robert J. Perez Chief Executive Officer 6:31 a.m. Oct. 20, 2014 - BusinessWire - BZX
Cubist to Announce Third Quarter 2014 Financial Results on Tuesday, October 21, 2014 8:01 a.m. Oct. 14, 2014 - BusinessWire - BZX
Cubist to Present New Data from Study of fidaxomicin in Children with Clostridium Difficile-Associated Diarrhea at IDWeek 2014 7:31 a.m. Oct. 8, 2014 - BusinessWire - BZX
Cubist Announces Continued Global Expansion with Opening of International Headquarters in Zurich 3:30 a.m. Sept. 18, 2014 - BusinessWire - BZX
Cubist to Present at Morgan Stanley Global Healthcare Conference 8:02 a.m. Aug. 25, 2014 - BusinessWire - BZX
Cubist Announces EMA Acceptance of Ceftolozane/Tazobactam Marketing Authorization Application for Review 6:30 a.m. Aug. 22, 2014 - BusinessWire - BZX
Cubist Pharmaceuticals Issues Voluntary Nationwide Recall of Nine Lots of CUBICIN (daptomycin for injection) 500 mg in 10 mL single use vials Following Complaints of Foreign Particulate Matter in Reconstituted Vials 8:05 a.m. Aug. 10, 2014 - BusinessWire - BZX
Cubist Pharmaceuticals Issues Voluntary U.S. Recall of Certain Lots of CUBICIN (daptomycin for injection) 500 mg in 10 mL single use vials Due to Presence of Particulate Matter 10:35 p.m. Aug. 6, 2014 - BusinessWire - BZX
Cubist Pharmaceuticals Issues Voluntary U.S. Recall of Certain Lots of CUBICIN (daptomycin for injection) 500 mg in 10 mL single use vials Due to Presence of Particulate Matter 10:35 p.m. Aug. 6, 2014 - BusinessWire - BZX
Biotech Equities Roundup -- Keryx Biopharma, Vertex Pharma, NPS Pharma, Cubist Pharma, and Idera Pharma 7:50 a.m. Aug. 6, 2014 - PR Newswire - PRF
Cubist’s Once-daily SIVEXTRO™ (tedizolid phosphate) Available for Physician and Hospital Order in I.V. and Oral Formulations 7:32 a.m. Aug. 5, 2014 - BusinessWire - BZX
Financial Results, Clinical Trial Initiations, Drug Designations, Appointments, and Study Results - Research Reports on Cubist, Jazz, InterMune, NPS Pharmaceuticals and ACADIA 8:00 a.m. July 30, 2014 - PR Newswire - PRF
Cubist to Present at August Investor Conference 8:00 a.m. July 28, 2014 - BusinessWire - BZX
Mark H.N. Corrigan, M.D., Julie H. McHugh, and William Hunter, M.D. to Serve on EPIRUS Board of Directors 10:50 a.m. July 15, 2014 - BusinessWire - BZX
Cubist to Announce Second Quarter 2014 Financial Results on Tuesday, July 22, 2014 8:01 a.m. July 15, 2014 - BusinessWire - BZX
Cidara Therapeutics - "Back to the Rodeo" 10:10 a.m. July 1, 2014 - ACCESSWIRE
Loading more headlines...
MarketWatch News on CBST
Cubist completes exacta, gets good news from FDA two days in a row 6:22 p.m. June 20, 2014 - Russ Britt
Earnings roundup: Cubist, Merck gain as HCA, Bristol-Myers slide 10:48 a.m. April 29, 2014 - Russ Britt
Three biopharma companies poised for product OKs in 2014: analyst 12:51 p.m. Jan. 6, 2014 - Russ Britt
Cubist, Agenus shares soar after experimental drugs pass muster 1:20 p.m. Dec. 16, 2013 - Russ Britt
Cubist, Trius shares keep rocking, while Optimer and Amgen struggle 12:56 p.m. July 31, 2013 - Russ Britt
Cubist Pharmaceuticals adds fire to merger frenzy with two buyouts 5:00 p.m. July 30, 2013 - Russ Britt
Never mind earnings, it's revenue that drives Cubist shares higher 10:19 a.m. July 19, 2013 - Russ Britt
Cubist Q2 profit down 65% amid higher costs 3:39 p.m. July 18, 2013 - MarketWatch.com
Cubist Pharmaceuticals shares leap late after ruling on patent cases 4:16 p.m. May 20, 2013 - Russ Britt
A few wild stock swings in health earnings 4:34 p.m. Jan. 23, 2013 - Russ Britt
Updates, advisories and surprises 4:01 p.m. Oct. 18, 2012 - MarketWatch
Cubist Pharmaceuticals third-quarter net climbs 3:20 p.m. Oct. 18, 2012 - Russ Britt
FactSet estimate on Cubist is 47 cents 3:12 p.m. Oct. 18, 2012 - Russ Britt
Cubist revenue: $238.1 million vs. $201.7 million 3:07 p.m. Oct. 18, 2012 - Russ Britt
Cubust Pharma net 55 cents vs. 33 cents 3:06 p.m. Oct. 18, 2012 - Russ Britt
Charting a bull/bear stalemate 10:52 a.m. Aug. 23, 2012 - Michael Ashbaugh
Hot stocks to watch 7:59 a.m. July 20, 2012 - MarketWatch.com
Cubist Pharma projects annual sales of $2 bln 12:25 p.m. June 11, 2012 - MarketWatch.com
Cubist Pharma profit jumps 45% on Cubicin boost 4:30 p.m. April 18, 2012 - MarketWatch.com
Bearish bets on four stocks 12:46 p.m. April 9, 2012 - The Trading Deck
Loading more headlines...
Advertisement
Other News on CBST
Making Money With Charles Payne: 11/17/14 6:00 p.m. Nov. 17, 2014 - FOXBusiness
Cubist Pharmaceuticals Inc. (CBST): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Nov. 14, 2014 - Zacks.com
10-Q: CUBIST PHARMACEUTICALS INC 9:04 a.m. Nov. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Cubist Pharmaceuticals (CBST) Upgraded From Hold to Buy 9:14 a.m. Nov. 5, 2014 - TheStreet.com
Wedbush Initiates Coverage On Cubist Pharmaceuticals 10:09 a.m. Nov. 4, 2014 - benzinga.com
Biotech Stock Roundup: Beat & Raise Quarter for Amgen, Celgene, Alexion, Biogen - Analyst Blog 12:28 p.m. Oct. 29, 2014 - Zacks.com
Why We Think Cubist Pharmaceuticals Has Incredible Upside 4:34 a.m. Oct. 29, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – MNKD CBST INCY ISIS 1:15 p.m. Oct. 23, 2014 - InvestorPlace.com
Cubist Pharmaceuticals' Q3 Earnings Beat Expectations - Analyst Blog 10:00 a.m. Oct. 23, 2014 - Zacks.com
Trade-Ideas: Cubist Pharmaceuticals (CBST) Is Today's "Storm The Castle" Stock 2:30 p.m. Oct. 22, 2014 - TheStreet.com
Hottest Healthcare Stocks Now – ACHC BSX CBST GSK 8:15 a.m. Oct. 22, 2014 - InvestorPlace.com
Cubist Pharmaceuticals' (CBST) CEO Mike Bonney on Q3 2014 Results - Earnings Call Transcript 10:30 p.m. Oct. 21, 2014 - Seeking Alpha
Cubist net income up 167% 6:14 p.m. Oct. 21, 2014 - Seeking Alpha
Wall Street Breakfast: IBM To Unload Semiconductor Unit - Report 6:33 a.m. Oct. 20, 2014 - Seeking Alpha
Benzinga's Weekend M&A Chatter 8:58 p.m. Oct. 19, 2014 - benzinga.com
Ironwood Pharma begins linaclotide label expansion trial 9:52 a.m. Oct. 16, 2014 - Seeking Alpha
Actavis Expands Antibiotics Presence With Durata Buy 9:58 a.m. Oct. 6, 2014 - Investors Business Daily
InsiderInsights.com Daily Round Up 10/2/14: FGP, INFI, AGCO, OPK 10:14 a.m. Oct. 3, 2014 - Seeking Alpha
FDA approves Salix/Progenics' Relistor 6:07 p.m. Sept. 29, 2014 - Seeking Alpha
Ad Comm supports approval of Moventig for OIC 8:35 a.m. Sept. 26, 2014 - Seeking Alpha
Loading more headlines...
Press Releases on CBST
European Antibiotic Awareness Day Highlights Need for Urgent Action 1:00 a.m. Nov. 17, 2014 - BusinessWire - BZX
Cubist Names Dr. Patrick Vink Chief Operating Officer 7:32 a.m. Nov. 5, 2014 - BusinessWire - BZX
Cubist to Present at Jefferies 2014 Healthcare Conference 9:01 a.m. Nov. 3, 2014 - BusinessWire - BZX
Technical Data on Biotech Equities - Intrexon, Keryx Biopharma, Spectrum Pharma, Sangamo BioSciences, and Cubist Pharma 8:15 a.m. Oct. 21, 2014 - PR Newswire - PRF
Cubist Pharmaceuticals Names Robert J. Perez Chief Executive Officer 6:31 a.m. Oct. 20, 2014 - BusinessWire - BZX
Cubist to Announce Third Quarter 2014 Financial Results on Tuesday, October 21, 2014 8:01 a.m. Oct. 14, 2014 - BusinessWire - BZX
Cubist to Present New Data from Study of fidaxomicin in Children with Clostridium Difficile-Associated Diarrhea at IDWeek 2014 7:31 a.m. Oct. 8, 2014 - BusinessWire - BZX
Cubist Announces Continued Global Expansion with Opening of International Headquarters in Zurich 3:30 a.m. Sept. 18, 2014 - BusinessWire - BZX
Cubist to Present at Morgan Stanley Global Healthcare Conference 8:02 a.m. Aug. 25, 2014 - BusinessWire - BZX
Cubist Announces EMA Acceptance of Ceftolozane/Tazobactam Marketing Authorization Application for Review 6:30 a.m. Aug. 22, 2014 - BusinessWire - BZX
Cubist Pharmaceuticals Issues Voluntary Nationwide Recall of Nine Lots of CUBICIN (daptomycin for injection) 500 mg in 10 mL single use vials Following Complaints of Foreign Particulate Matter in Reconstituted Vials 8:05 a.m. Aug. 10, 2014 - BusinessWire - BZX
Cubist Pharmaceuticals Issues Voluntary U.S. Recall of Certain Lots of CUBICIN (daptomycin for injection) 500 mg in 10 mL single use vials Due to Presence of Particulate Matter 10:35 p.m. Aug. 6, 2014 - BusinessWire - BZX
Cubist Pharmaceuticals Issues Voluntary U.S. Recall of Certain Lots of CUBICIN (daptomycin for injection) 500 mg in 10 mL single use vials Due to Presence of Particulate Matter 10:35 p.m. Aug. 6, 2014 - BusinessWire - BZX
Biotech Equities Roundup -- Keryx Biopharma, Vertex Pharma, NPS Pharma, Cubist Pharma, and Idera Pharma 7:50 a.m. Aug. 6, 2014 - PR Newswire - PRF
Cubist’s Once-daily SIVEXTRO™ (tedizolid phosphate) Available for Physician and Hospital Order in I.V. and Oral Formulations 7:32 a.m. Aug. 5, 2014 - BusinessWire - BZX
Financial Results, Clinical Trial Initiations, Drug Designations, Appointments, and Study Results - Research Reports on Cubist, Jazz, InterMune, NPS Pharmaceuticals and ACADIA 8:00 a.m. July 30, 2014 - PR Newswire - PRF
Cubist to Present at August Investor Conference 8:00 a.m. July 28, 2014 - BusinessWire - BZX
Mark H.N. Corrigan, M.D., Julie H. McHugh, and William Hunter, M.D. to Serve on EPIRUS Board of Directors 10:50 a.m. July 15, 2014 - BusinessWire - BZX
Cubist to Announce Second Quarter 2014 Financial Results on Tuesday, July 22, 2014 8:01 a.m. July 15, 2014 - BusinessWire - BZX
Cidara Therapeutics - "Back to the Rodeo" 10:10 a.m. July 1, 2014 - ACCESSWIRE
Loading more headlines...
(0)
(0)Scroll down for more posts ▼